OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Malignant Melanoma: Contemporary Management

home / peer-exchange / malignant-melanoma-management
Management of Stage III Melanoma

EP. 1: Management of Stage III Melanoma

June 28th 2019
Molecular Testing for Stage III Melanoma

EP. 2: Molecular Testing for Stage III Melanoma

June 28th 2019
Stage III Melanoma: Adjuvant Therapy Trials

EP. 3: Stage III Melanoma: Adjuvant Therapy Trials

June 28th 2019
Stage III Melanoma: Personalized Management

EP. 4: Stage III Melanoma: Personalized Management

June 28th 2019
Stage III Melanoma: Changes to Staging System

EP. 5: Stage III Melanoma: Changes to Staging System

June 28th 2019
Stage III Melanoma: Neoadjuvant Therapy

EP. 6: Stage III Melanoma: Neoadjuvant Therapy

June 28th 2019
Pooled Analysis of Neoadjuvant Therapy

EP. 7: Pooled Analysis of Neoadjuvant Therapy

June 28th 2019
Progression on Adjuvant Therapy

EP. 8: Progression on Adjuvant Therapy

June 28th 2019
Frontline Therapy in Melanoma

EP. 9: Frontline Therapy in Melanoma

June 28th 2019
Clinical Trials for Frontline Therapy in Melanoma

EP. 10: Clinical Trials for Frontline Therapy in Melanoma

June 28th 2019
BRAF/MEK Inhibitors in Metastatic Melanoma

EP. 11: BRAF/MEK Inhibitors in Metastatic Melanoma

June 28th 2019
Metastatic Melanoma Brain Metastases

EP. 12: Metastatic Melanoma Brain Metastases

June 28th 2019
Intralesional Therapy for Metastatic Melanoma

EP. 13: Intralesional Therapy for Metastatic Melanoma

June 28th 2019
Melanoma: Progression After Immunotherapy

EP. 14: Melanoma: Progression After Immunotherapy

June 28th 2019
Novel Agents for the Treatment of Melanoma

EP. 15: Novel Agents for the Treatment of Melanoma

June 28th 2019
Future of Treating Melanoma

EP. 16: Future of Treating Melanoma

June 28th 2019
The Role of BRAF Mutations in Melanoma

EP. 17: The Role of BRAF Mutations in Melanoma

June 28th 2019
Combination Therapy in Mutated Melanoma

EP. 18: Combination Therapy in Mutated Melanoma

June 28th 2019
Management of Patients with BRAF-Mutated Melanoma

EP. 19: Management of Patients with BRAF-Mutated Melanoma

June 28th 2019
The Use of Dual Targeted Therapy in Metastatic Melanoma

EP. 20: The Use of Dual Targeted Therapy in Metastatic Melanoma

June 28th 2019
Unmet Needs and Future Treatments of Metastatic Melanoma

EP. 21: Unmet Needs and Future Treatments of Metastatic Melanoma

June 28th 2019

Latest Conference Coverage

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact